sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Chronic kidney disease treatment Market Size, Share, Competitive Landscape and Trend Analysis Report by Treatment, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2032

Chronic kidney disease treatment Market Size, Share, Competitive Landscape and...

Home / Categories / Healthcare
Chronic kidney disease treatment Market Size, Share, Competitive Landscape and Trend Analysis Report by Treatment, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2032
Chronic kidney disease treatment Market...
Report Code
RO1/128/1190

Publish Date
24/Jun/2024

Pages
200
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The global chronic kidney disease treatment market revenue was around US$ 33.2 billion in 2023 and is estimated to reach US$ 47.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 4% during the forecast period from 2024 to 2032.
A chronic illness known as chronic kidney disease (CKD) is characterized by a progressive loss of kidney function over time. The kidneys are essential for controlling blood pressure, electrolyte balance, red blood cell production, and the removal of waste materials, extra fluid, and toxins from the bloodstream. Depending on the degree of kidney function, chronic kidney disease (CKD) usually begins slowly and advances through several stages, from mild to severe. Diabetes, high blood pressure, hypertension, and specific kidney infections or conditions are the most common causes of chronic kidney disease (CKD). Therefore, managing and delaying the progression of kidney damage and its related complications is the goal of chronic kidney disease (CKD) treatment, which encompasses a variety of medical procedures and approaches.
Factors Influencing Market Growth
- The prevalence of CKD cases is increasing, especially in the aging population. This is increasing the demand for chronic kidney disease treatment, thus expanding the market.
- CKD can develop and worsen as a result of altering lifestyle choices like smoking, drinking too much alcohol, eating poorly, and not getting enough exercise. As major risk factors for chronic kidney disease (CKD), these behaviors can result in conditions like obesity, diabetes, and hypertension. Therefore, the industry's increased demand for treatments for chronic kidney disease is fueling the market's expansion.
- Public awareness campaigns like education campaigns, screening programs, and community outreach initiatives about chronic kidney disease (CKD) and its risk factors are becoming more and more prevalent. This is increasing the demand for chronic kidney disease treatment, thus propelling market growth.
- The high cost of treatment for chronic kidney disease (CKD) may hamper market growth.
Impact of COVID-19
COVID-19 negatively impacted the market. This is because regular healthcare services, such as routine check-ups, consultations, and follow-up visits, were disrupted by lockdowns, social distancing measures, and overburdened healthcare systems. These alterations might have had an impact on how CKD patients were managed and observed. Moreover, because of their weakened immune systems and underlying medical conditions, patients with chronic kidney disease (CKD) are regarded as a high-risk group for developing a severe COVID-19 infection. Patients with chronic kidney disease (CKD) were likely more susceptible to COVID-19, which led to an increased need for preventive measures, hospital stays, and modifications to treatment plans.
Regional Insights
Asia-Pacific is expected to have the highest CAGR over the course of the forecast period. This is due to the existence of a sizable patient population, rising public awareness of the potential treatments for chronic kidney disease, and rising healthcare spending. Additionally, a rise in the prevalence of chronic kidney disease and an increase in the number of people getting regular checkups are credited with this region's market growth. As a result, there is a rise in the need for primary care services like kidney disease prevention centers for diagnosis and treatment. Furthermore, the region's varied patient pool and a significant increase in the geriatric population base have made it a hub for kidney disease. Furthermore, significant opportunities for market growth are anticipated to be provided by the growth in R&D activities as well as the established presence of domestic companies in the region.
Leading Competitors
- AbbVie Inc.
- Fresenius SE and Co. KGaA
- Johnson & Johnson
- AstraZeneca plc
- Becton
- Dickinson and Company
- B. Braun SE
- Teva Pharmaceutical Industries Ltd.
- Baxter International Inc.
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Other Prominent Players

Segmentation Analysis
The global chronic kidney disease treatment market segmentation focuses on end user, treatment, and region.
Segmentation based on End User
- Hospital
- Dialysis Center
- Others

Segmentation based on Treatment
- Drugs
- Erythropoietic Stimulating agents
- Ace Inhibitors
- Diuretics
- Others
- Dialysis
- Equipment
- Consumables

Segmentation based on Region

- North America
- The U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest Of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com